PolyMedica to Provide its Insights into Recently Announced Competitive Bidding Legislation in Conference Call

  
    
  
  
    
      PolyMedica Corporation (NASDAQ: PLMD) today announced that it will host 
      a conference call on Wednesday, April 4, 2007, at 9:00 a.m. Eastern Time 
      to provide its insights into the rule on competitive bidding that was 
      released by the Centers for Medicare & Medicaid Services on April 2, 
      2007.
    
    
      About PolyMedica
    
    
      For more than a decade, PolyMedica Corporation has been the nation’s 
      largest provider of blood glucose testing supplies and related services 
      to people with diabetes and today serves more than 925,000 active 
      patients. The Company is expanding its portfolio of products and 
      services, from patient education to prescription drugs, to help people 
      better manage their conditions and maintain their health. Through 
      proactive patient outreach, convenient home delivery and administrative 
      support, PolyMedica makes it simple for patients to obtain the supplies 
      and medications they need, while encouraging compliance with physicians’ 
      orders. More information about PolyMedica can be found on the Company’s 
      website at www.polymedica.com.
    
    
      This press release contains forward-looking statements as that term 
      is defined in the Private Securities Litigation Reform Act of 1995. Such 
      forward-looking statements are subject to risks and uncertainties, which 
      could cause actual results to differ materially from those anticipated. 
      Such risks and uncertainties include, but are not limited to, rules 
      and regulations promulgated under the Act, unanticipated changes in 
      Medicare reimbursement, successful participation in new reimbursement 
      programs, outcomes of government reviews, inquiries, investigations and 
      related litigation, continued compliance with government regulations, 
      fluctuations in customer demand, management of rapid growth, competition 
      from other healthcare product vendors, timing and acceptance of new 
      product introductions, general economic conditions, geopolitical events 
      and regulatory changes, as well as other especially relevant risks 
      detailed in the Company’s filings with the 
      Securities and Exchange Commission, including its Annual Report on Form 
      10-K for the period ended March 31, 2006, and Quarterly Reports on Form 
      10-Q for the periods ended June 30, 2006, September 30, 2006 and 
      December 31, 2006. The information set forth herein should be 
      read in light of such risks. The Company assumes no obligation to 
      update the information contained in this press release.